How Long Do Opioids Stay in Your System? (2026 Guide)

Opioids are metabolized primarily by the liver through various enzymatic pathways. The specific metabolic pathway depends on the opioid:

Heroin is rapidly metabolized to 6-MAM (6-monoacetylmorphine) within minutes, then to morphine. The 6-MAM metabolite is the definitive marker for heroin use (as opposed to morphine from other sources), but it has a very short detection window of only 2-8 hours in urine.

Morphine and codeine are metabolized through glucuronidation. Codeine is partially converted to morphine (about 10% of a codeine dose), which is why codeine users may test positive for both codeine and morphine.

Oxycodone is metabolized by the liver enzyme CYP3A4 to noroxycodone and by CYP2D6 to oxymorphone. These metabolites are what expanded drug tests detect.

Hydrocodone is metabolized to hydromorphone and norhydrocodone. Some individuals who are ultra-rapid CYP2D6 metabolizers may convert more hydrocodone to hydromorphone.

Fentanyl is metabolized primarily to norfentanyl by CYP3A4. Norfentanyl is the metabolite detected by specific fentanyl immunoassays.

Methadone has the longest half-life (24-36 hours), which is why it is used for maintenance therapy — steady blood levels can be maintained with once-daily dosing. This long half-life also means methadone has the longest urine detection window among commonly tested opioids.

This is one of the most important distinctions in drug testing: NOT all opioids are detected on all drug test panels.

Standard DOT 5-panel test: Tests for 'opiates' — specifically morphine, codeine, and heroin (6-MAM) at 2000 ng/mL initial / 2000 ng/mL confirmation. This panel does NOT detect oxycodone, hydrocodone, fentanyl, methadone, tramadol, or buprenorphine.

10-panel test: Adds methadone to the opioid testing. Some 10-panel tests also add expanded opioid testing (oxycodone, hydrocodone), but this varies by laboratory.

12-panel test: Typically includes expanded opioid testing — oxycodone and hydrocodone (sometimes listed as 'extended opioids'). Also includes MDMA and typically methadone.

Fentanyl: Requires a SPECIFIC fentanyl immunoassay or LC-MS/MS test. It is NOT included on 5-panel, standard 10-panel, or even most 12-panel tests. However, due to the fentanyl crisis, many employers and testing programs now add specific fentanyl testing.

Tramadol: Requires specific testing. Not on standard panels.

Buprenorphine (Suboxone/Subutex): Requires specific testing. Not on standard panels, but commonly tested for in addiction treatment monitoring.

Why this matters: If you are taking prescribed oxycodone and your employer only uses a 5-panel test, the oxycodone will NOT be detected. However, if they use a 10-panel or expanded panel, it will be detected — and you should inform the MRO of your prescription.

Opiate immunoassay tests (standard 5-panel) are known to have several cross-reactivity issues:

Poppy seeds: This is the most well-known cause of opiate false positives. Poppy seeds contain trace amounts of morphine and codeine. Eating a poppy seed bagel or poppy seed cake can produce morphine levels above the old 300 ng/mL cutoff. In 2010, SAMHSA raised the federal cutoff to 2000 ng/mL specifically to reduce poppy seed false positives. However, at the 2000 ng/mL cutoff, consuming large amounts of poppy seeds can still occasionally cause a positive result.

Quinolone antibiotics: Levofloxacin (Levaquin) and ofloxacin have been reported to cause false positives on some opiate immunoassays.

Dextromethorphan (DXM): Found in many over-the-counter cough medications (Robitussin DM, Delsym). Can occasionally cross-react with opiate assays at high doses.

Rifampin: An antibiotic used for tuberculosis treatment. Has been reported to cause false positives.

Diphenhydramine (Benadryl): At very high doses, has been reported to occasionally trigger false positives on some opiate assays.

GC-MS/LC-MS/MS confirmation testing is highly specific and can distinguish between different opioids and eliminate false positive concerns. Always request confirmation testing if you believe you have a false positive. Inform the MRO about any prescription or OTC medications you take.

Most opioids are relatively short-acting and are cleared from the body within a few days. Here are evidence-based approaches to support natural elimination:

Stop using completely: This is critical. Opioids have varying half-lives — heroin/morphine clear relatively quickly (2-4 hours half-life), while methadone takes much longer (24-36 hours).

Stay hydrated: Opioids and their metabolites are excreted primarily through urine. Adequate hydration supports kidney function and helps clear metabolites. Do not overhydrate before a test.

Maintain normal activity: Light to moderate activity supports overall metabolism. Opioids are not stored in fat the way THC is, so exercise does not have the same 'release' effect.

Be aware of extended-release formulations: If you take extended-release opioids (OxyContin, MS Contin, Methadose), the drug is released slowly over 12-24 hours. Detection windows may be slightly longer compared to immediate-release formulations.

For prescribed users: If you take prescribed opioids and have an upcoming drug test, do NOT stop taking your medication without medical guidance. Continue your prescribed regimen and inform the MRO of your prescription if the test comes back positive.

IMPORTANT: If you are dependent on opioids, do NOT stop abruptly without medical supervision. Opioid withdrawal, while rarely life-threatening, can be extremely uncomfortable and may lead to relapse. Seek medical help for a supervised taper or medication-assisted treatment (MAT) with buprenorphine or methadone. Call SAMHSA at 1-800-662-4357 for treatment referrals.

Opioid testing in employment has become more complex as the opioid crisis has evolved. Key points for job seekers:

Prescribed opioids: If you take prescribed opioid medication (oxycodone, hydrocodone, etc.) and test positive, the MRO will verify your prescription before reporting the result. A verified prescription means the result is reported as negative (for non-DOT tests) or may require further evaluation (for DOT tests).

DOT-regulated positions: This is a critical distinction. Even with a valid prescription, opioid use may disqualify you from DOT safety-sensitive duties. CDL drivers, pilots, and other DOT-regulated employees cannot perform safety-sensitive functions while taking Schedule II opioids in most cases. The MRO must determine whether your medication is consistent with safe performance.

Medication-Assisted Treatment (MAT): Employees on methadone or buprenorphine (Suboxone) for opioid use disorder face additional considerations. Non-DOT employers generally cannot discriminate against employees in MAT programs (this may be protected under the ADA as treatment for a disability). For DOT-regulated positions, methadone is generally prohibited, while buprenorphine may be allowed with MRO clearance on a case-by-case basis.

Fentanyl testing expansion: Many employers are adding specific fentanyl testing to their panels due to the ongoing crisis. If your employer uses an expanded panel, fentanyl will be detected even though it is not on the standard 5-panel.

Opioid legal status varies by substance:

Heroin: Schedule I (no recognized medical use, high abuse potential). Possession is a serious felony in all 50 states.

Morphine, oxycodone, hydrocodone, fentanyl, methadone: Schedule II (recognized medical use, high abuse potential). Legal with a valid prescription. Illegal to possess without a prescription.

Codeine (in certain formulations): Schedule III-V depending on formulation. Combination products with codeine (Tylenol with codeine) are Schedule III.

Tramadol: Schedule IV (lower abuse potential). Legal with a prescription.

Buprenorphine (Suboxone/Subutex): Schedule III. Used for opioid use disorder treatment. As of 2023, the X-waiver requirement was eliminated — any DEA-registered prescriber can now prescribe buprenorphine for opioid use disorder.

Opioid-related criminal justice reform is an active area of legislation. Many states have enacted or are considering: drug court and diversion programs for opioid possession, Good Samaritan laws (protecting people who call 911 for overdose), expanded access to naloxone (Narcan) for overdose reversal, and sentencing reform for low-level possession offenses.

For people with prior opioid convictions: Check your state's expungement and record-clearing laws at secondchanceinfo.com/expungement. Many states have created specific provisions for drug possession convictions. Drug court completion may also qualify you for record clearing.